Latest Breaking News On - Vishal manchanda - Page 1 : comparemela.com

Cipla promoter group sells 2 53% stake to generate liquidity

Cipla promoter group sells 2 53% stake to generate liquidity
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Rumana hamiedShririn hamiedTushar manudhaneSamina hamiedShirin hamiedVishal manchandaOkasa pharmaInstitutional research at systematixOkasa pharma privateMotilal oswal financial servicesCipla limitedOkasa pharma private limitedSenior vice presidentInstitutional researchMotilal oswal financial

Why Mankind Pharma needs more boosters

While there are no downside risks to Mankind’s earnings growth, pricey valuations also do not offer comfort. Moreover, one should be wary of the regulatory risks in the pharmaceutical sector, analysts say

Tausif shaikhVishal manchandaPrega newsAntique stock brokingSystematix sharesPradhan mantri bhartiya janaushadhi pariyojanaMankind pharmaGaso fastMankind pharma share

India pharma companies develop versions of Wegovy to get in on weight-loss windfall

Indian drugmakers are developing their versions of Novo Nordisk s weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy s, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand.

Sun pharmaVishal manchandaUmang vohraNitin agarwalEli lillyWorld obesity federation atlasExpert market researchNovo nordiskWorld obesity federationExpert marketWegovy indiaIndia pharma companiesWeight loss treatmentGeneric drugmakers

Health: India pharma companies develop versions of Wegovy to get in on weight-loss windfall

Health: India pharma companies develop versions of Wegovy to get in on weight-loss windfall
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

Eli lillySun pharmaVishal manchandaNitin agarwalUmang vohraWorld obesity federation atlasExpert market researchNovo nordiskWorld obesity federationExpert market

Sun Pharma, Cipla, Dr Reddy s, Lupin in race for slice of a $100 billion a year pie

Indian pharma companies have started developing their own versions of Novo Nordisk's wildly in demand Wegovy.

Umang vohraEli lillyVishal manchandaSun pharmaNovo nordiskWorld obesity federation atlasWorld obesity federationIndia sun pharmaDr reddy 039 sPharmaceutical companiesMarket opportunity00 billioncompetitionIndustry leadersMarket share